US FDA Approves 'Mounjaro' to Protect Diabetes Patients from Fatal Risk

The U.S. Food and Drug Administration (FDA) announced its approval of the diabetes drug 'Mounjaro' to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes.